Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PROCEPT BioRobotics Corporation (PRCT : NSDQ)

• Company Description    PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics, formerly known as PROCEPT THERAP, is based in San Jose, California. Number of Employees: 888

• Price / Volume Information    Yesterday's Closing Price: $20.07 Daily Weekly Monthly 20 Day Moving Average: 924,609 shares Shares Outstanding: 57.27 (millions) Market Capitalization: $1,149.48 (millions) Beta: 0.91 52 Week High: $40.10 52 Week Low: $16.67 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -8.56% -6.07% 12 Week -7.60% -8.71% Year To Date -36.21% -42.47%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 150 Baytech Drive - San Jose,CA 95134 USA ph: 650-232-7200 fax: - ir@procept-biorobotics.com http://www.procept-biorobotics.com

• General Corporate Information    Officers Larry Wood - President; Chief Executive Officer and Director Thomas M. Prescott - Director and Chairman of the Board Kevin Waters - Chief Financial Officer Antal Desai - Director Amy Dodrill - Director Peer Information PROCEPT BioRobotics Corporation (ABMD) PROCEPT BioRobotics Corporation (DMDS) PROCEPT BioRobotics Corporation (CPWY.) PROCEPT BioRobotics Corporation (EQUR) PROCEPT BioRobotics Corporation (ECIA) PROCEPT BioRobotics Corporation (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 74276L105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/03/26 Share - Related Items Shares Outstanding: 57.27 Most Recent Split Date: (:1) Beta: 0.91 Market Capitalization: $1,149.48 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.39 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.67 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 17.38% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.36 Price/Cash Flow: - Price / Sales: 3.41 EPS Growth vs. Year Ago Period: -34.29% vs. Previous Quarter: 16.07% Sales Growth vs. Year Ago Period: 19.34% vs. Previous Quarter: 13.67% ROE 06/30/26 - -30.62 03/31/26 - -27.70 12/31/25 - -25.13 ROA 06/30/26 - -22.10 03/31/26 - -20.29 12/31/25 - -18.63 Current Ratio 06/30/26 - 6.55 03/31/26 - 6.73 12/31/25 - 6.85 Quick Ratio 06/30/26 - 5.35 03/31/26 - 5.51 12/31/25 - 5.77 Operating Margin 06/30/26 - -32.53 03/31/26 - -31.82 12/31/25 - -31.02 Net Margin 06/30/26 - -32.53 03/31/26 - -31.82 12/31/25 - -31.02 Pre-Tax Margin 06/30/26 - -32.49 03/31/26 - -31.76 12/31/25 - -30.96 Book Value 06/30/26 - 5.97 03/31/26 - 6.11 12/31/25 - 6.55 Inventory Turnover 06/30/26 - 1.65 03/31/26 - 1.65 12/31/25 - 1.68 Debt-to-Equity 06/30/26 - 0.15 03/31/26 - 0.15 12/31/25 - 0.14 Debt-to-Capital 06/30/26 - 13.20 03/31/26 - 12.94 12/31/25 - 12.36

Powered by Zacks Investment Research ©